Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+1.12%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$28.3B
AUM Growth
-$930M
(-3.2%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
43.26%
Holding
1,183
New
46
Increased
601
Reduced
483
Closed
43
Top Buys
| 1 |
Tesla
TSLA
|
$424M |
| 2 |
iShares China Large-Cap ETF
FXI
|
$316M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
$132M |
| 4 |
VanEck Gold Miners ETF
GDX
|
$79.4M |
| 5 |
iShares MSCI South Korea ETF
EWY
|
$48.4M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$469M |
| 2 |
NVIDIA
NVDA
|
$240M |
| 3 |
Broadcom
AVGO
|
$186M |
| 4 |
Marvell Technology
MRVL
|
$179M |
| 5 |
TSMC
TSM
|
$88.9M |
Sector Composition
| 1 | Technology | 41.4% |
| 2 | Financials | 10.43% |
| 3 | Consumer Discretionary | 7.12% |
| 4 | Healthcare | 4.51% |
| 5 | Industrials | 2.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Equitable Holdings
EQH
$16B
| $338K | ﹤0.01% |
7,157
-216
| -3% | -$10.2K |
|
1002
Organon & Co
OGN
$2.7B
| $338K | ﹤0.01% |
22,627
+1,194
| +6% | +$17.8K |
|
1003
Loar Holdings
LOAR
$7.16B
| $336K | ﹤0.01% |
4,551
+1,700
| +60% | +$126K |
|
1004
Astria Therapeutics
ATXS
$424M
| $336K | ﹤0.01% |
37,571
-15,810
| -30% | -$141K |
|
1005
Coherent
COHR
$15.2B
| $335K | ﹤0.01% |
3,533
-1
| -0% | -$95 |
|
1006
ODP
ODP
$668M
| $334K | ﹤0.01% |
14,671
+75
| +0.5% | +$1.71K |
|
1007
Fidelity National Financial
FNF
$16.5B
| $333K | ﹤0.01% |
5,937
-53
| -0.9% | -$2.98K |
|
1008
Reliance Steel & Aluminium
RS
$15.7B
| $333K | ﹤0.01% |
1,236
-32
| -3% | -$8.62K |
|
1009
Quanex
NX
$836M
| $331K | ﹤0.01% |
13,653
+2,955
| +28% | +$71.6K |
|
1010
The RealReal
REAL
$999M
| $330K | ﹤0.01% |
+30,147
| New | +$330K |
|
1011
Avantor
AVTR
$9.07B
| $328K | ﹤0.01% |
15,546
-129
| -0.8% | -$2.72K |
|
1012
Aecom
ACM
$16.8B
| $327K | ﹤0.01% |
3,061
-30
| -1% | -$3.21K |
|
1013
Graco
GGG
$14.2B
| $325K | ﹤0.01% |
3,857
-38
| -1% | -$3.2K |
|
1014
Y-mAbs Therapeutics
YMAB
$390M
| $323K | ﹤0.01% |
41,255
+6,178
| +18% | +$48.4K |
|
1015
Reinsurance Group of America
RGA
$12.8B
| $321K | ﹤0.01% |
1,504
-15
| -1% | -$3.2K |
|
1016
Churchill Downs
CHDN
$7.18B
| $321K | ﹤0.01% |
2,402
+55
| +2% | +$7.35K |
|
1017
Shift4
FOUR
$6.01B
| $318K | ﹤0.01% |
+3,067
| New | +$318K |
|
1018
Edgewise Therapeutics
EWTX
$1.64B
| $318K | ﹤0.01% |
11,906
-1,338
| -10% | -$35.7K |
|
1019
Ryder
R
$7.64B
| $314K | ﹤0.01% |
2,004
-51
| -2% | -$8K |
|
1020
SAP
SAP
$313B
| $310K | ﹤0.01% |
+1,261
| New | +$310K |
|
1021
Axsome Therapeutics
AXSM
$6.25B
| $307K | ﹤0.01% |
3,630
-1,054
| -23% | -$89.2K |
|
1022
EVgo
EVGO
$529M
| $306K | ﹤0.01% |
75,454
-44,728
| -37% | -$181K |
|
1023
Trip.com Group
TCOM
$47.6B
| $304K | ﹤0.01% |
4,429
-778
| -15% | -$53.4K |
|
1024
Performance Food Group
PFGC
$16.5B
| $301K | ﹤0.01% |
3,559
-34
| -0.9% | -$2.88K |
|
1025
Winmark
WINA
$1.7B
| $299K | ﹤0.01% |
760
-421
| -36% | -$165K |
|